Neutralizing antibodies after infection with dengue 1 virus

Emerging Infectious Diseases

Volumn 13, Issue 2, 2007, Pages 282-286

  Guzman, Maria G ^a   Alvarez, Mayling ^a   Rodriguez Roche, Rosmari ^a   Bernardo, Lídice ^a   Montes, Tibaire ^b   Vazquez, Susana ^a   Morier, Luis ^a   Alvarez, Angel ^a   Gould, Ernest A ^c   Kourí, Gustavo ^a   Halstead, Scott B ^d  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^d Pediatric Dengue Vaccine Initiative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CUBA; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; VIRUS STRAIN;

EID: 33846659386     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1302.060539     Document Type: Article

References (27)

1. Cantelar de Francisco N, Fernandez A, Albert Molina L, Perez Balbis E. [Survey of dengue in Cuba. 1978-1979]. Rev Cubana Med Trop. 1981;33:72-8.
2. Mas P. Dengue fever in Cuba in 1977: some laboratory aspects. In: Proceedings of Dengue in the Caribbean, 1977; 1979 May 8-11; Montego Bay, Jamaica. Washington: Pan American Health Organization; 1979. p. 40-2.
3. Sariol CA, Pelegrino JL, Martinez A, Arteaga E, Kouri G, Guzman MG. Detection and genetic relationship of dengue virus sequences in seventeen-year-old paraffin-embedded samples from Cuba. Am J Trop Med Hyg. 1999;61:994-1000.
4. Alvarez M, Guzman MG, Rosario D, Vazquez S, Pelegrino JL, Sariol CA, et al. [Direct sequencing of an amplified product from a serum sample]. Rev Cubana Med Trop. 1996;48:53-5.
5. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Santos M, et al. Dengue haemorrhagic fever in Cuba. II. Clinical investigations. Trans R Soc Trop Med Hyg. 1984;78:239-41.
6. Guzman MG, Kouri GP, Bravo J, Calunga M, Soler M, Vazquez S, et al. Dengue haemorrhagic fever in Cuba. I. Serological confirmation of clinical diagnosis. Trans R Soc Trop Med Hyg. 1984;78:235-8.
7. Kouri G, Guzman MG, Bravo J. Hemorrhagic dengue in Cuba: history of an epidemic. Bull Pan Am Health Organ. 1986;20:24-30.
8. Guzman MG, Deubel V, Pelegrino JL, Rosario D, Marrero M, Sariol C, et al. Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. Am J Trop Med Hyg. 1995;52:241-6.
9. Rodriguez-Roche R, Alvarez M, Gritsun T, Rosario D, Halstead S, Kouri G, et al. Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic. Arch Virol. 2005;150:415-25.
10. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol. 2000;152:793-9.
11. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg. 1990;42:179-84.
12. Guzman MG, Alvarez M, Rodriguez R, Rosario D, Vazquez S, Valdes L, et al. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis. 1999;3:130-5.
13. Guzman MG, Kouri G, Valdes L, Bravo J, Vazquez S, Halstead SB. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica. 2002;11:223-7.
14. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg. 1952;1:30-50.
15. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40:444-51.
16. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, et al. Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet. 1999;354:1431-4.
17. Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, Felices V, et al. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet. 2002;360:310-2.
18. Kochel TJ, Watts DM, Gozalo AS, Ewing DF, Porter KR, Russell KL. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis. 2005;191:1000-4.
19. Kouri G, Guzman MG, Valdes L, Carbonel I, del Rosario D, Vazquez S, et al. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis. 1998;4:89-92.
20. Valdes L, Guzman MG, Kouri G, Delgado J, Carbonell I, Cabrera MV, et al. [Epidemiology of dengue and hemorrhagic dengue in Santiago, Cuba 1997]. Rev Panam Salud Publica. 1999;6:16-25.
21. Leitmeyer KC, Vaughn DW, Watts DM, Salas R, Villalobos de Chacon I, Ramos C, et al. Dengue virus structural differences that correlate with pathogenesis. J Virol. 1999;73:4738-47.
22. Fernandez RJ, Vazquez S. Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz. 1990;85:347-51.
23. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol. 1985;22:250-4.
24. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967;99:285-90.
25. Guzman MG, Kouri G, Bravo J, Soler M, Martinez E. Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic. Mem Inst Oswaldo Cruz. 1991;86:367.
26. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis. 2004;189:990-1000.
27. Halstead S, Russ SB. Subclinical Japanese encephalitis. II. Antibody responses of Americans to single exposure to JE virus. Am J Hyg. 1962;75:202-11.